Estudio sobre la expresión de galanina en tumores melanocitarios

[1]  J. Haycock,et al.  α-Melanocyte stimulating hormone, inflammation and human melanoma , 2006, Peptides.

[2]  M. Nowicki,et al.  Prognostic value of stage IV neuroblastoma metastatic immunophenotype in the bone marrow: preliminary report , 2006, Journal of Clinical Pathology.

[3]  M. Mihm,et al.  Prognosticators of melanoma, the melanoma report, and the sentinel lymph node , 2006, Modern Pathology.

[4]  A. Berger,et al.  Galanin and galanin receptors in human cancers , 2005, Neuropeptides.

[5]  A. Klausegger,et al.  Expression of neuropeptide galanin and galanin receptors in human skin. , 2004, The Journal of investigative dermatology.

[6]  T. Hökfelt,et al.  Galanin in pituitary adenomas , 2004, Regulatory Peptides.

[7]  A. Hermann,et al.  Galanin receptor subtype GalR2 mediates apoptosis in SH-SY5Y neuroblastoma cells. , 2004, Endocrinology.

[8]  M. El-Salhy,et al.  Direct effects of octreotide, galanin and serotonin on human colon cancer cells. , 2003, Oncology reports.

[9]  Sonja Ständer,et al.  Modern aspects of cutaneous neurogenic inflammation. , 2003, Archives of dermatology.

[10]  M. Vrontakis.  Galanin: a biologically active peptide. , 2002, Current drug targets. CNS and neurological disorders.

[11]  J. Haycock,et al.  Melanoma Cell Attachment, Invasion, and Integrin Expression is Upregulated by Tumor Necrosis Factor α and Suppressed by α Melanocyte Stimulating Hormone , 2002 .

[12]  R. Granstein,et al.  Neuropeptides and neuroendocrine hormones in ultraviolet radiation-induced immunosuppression. , 2002, Methods.

[13]  Shosuke Ito,et al.  Human melanocortin 1 receptor variants, receptor function and melanocyte response to UV radiation. , 2002, Journal of cell science.

[14]  A. Berger,et al.  Elevated Expression of Galanin Receptors in Childhood Neuroblastic Tumors , 2002, Neuroendocrinology.

[15]  M. Landry,et al.  Galanin and galanin receptor expression in neuroblastic tumours: correlation with their differentiation status , 2002, British Journal of Cancer.

[16]  J. Haycock,et al.  Melanoma cell attachment, invasion, and integrin expression is upregulated by tumor necrosis factor alpha and suppressed by alpha melanocyte stimulating hormone. , 2002, The Journal of investigative dermatology.

[17]  T. Land,et al.  Galanin receptor subtypes and ligand binding , 2000, Neuropeptides.

[18]  A. Lazaris,et al.  Immunodetection of gastrin-releasing peptide in malignant melanoma cells , 2000, Melanoma research.

[19]  F. Pierau,et al.  Inhibitory modulation of cutaneous vascular responses by endogenous galanin in the pigeon , 1999, Neuroscience Letters.

[20]  M. Waters,et al.  Up-regulation of growth hormone receptor immunoreactivity in human melanoma. , 1999, Anticancer research.

[21]  Ohashi,et al.  Immunoreactivity of α‐melanocyte‐stimulating hormone, adrenocorticotrophic hormone and β‐endorphin in cutaneous malignant melanoma and benign melanocytic naevi , 1998, The British journal of dermatology.

[22]  T. Hökfelt,et al.  Central and peripheral expression of galanin in response to inflammation , 1995, Neuroscience.

[23]  J. Mayaux,et al.  Molecular cloning of a functional human galanin receptor. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[24]  T. Sano,et al.  Galanin immunoreactivity in neuroendocrine tumors. , 1991, Archives of pathology & laboratory medicine.